1. Acampa M, Lazzerini PE, Martini G. Letter by Acampa et al. Regarding Article, “Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage in patients with a history of migraine”. Stroke 2021; 52: e82-e82.
2.
Daou BJ, Koduri S, Thompson BG, Chaudhary N, Pandey AS. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage. CNS Neurosci Ther 2019; 25: 1096-1112.
3.
Fouad AM, Abdel Naseer M, Farghaly M, Hegazy MI. New algorithmic approach for easier and faster extended disability status scale calculation. Mult Scler J Exp Transl Clin 2023; 9: 20552173231155055.
4.
Hsiang-Yi CS. Subarachnoid hemorrhage. Continuum (Minneapolis, Minn.) 2021; 27: 1201-1245.
5.
Hughes JD, Bond KM, Mekary RA, et al. Estimating the global incidence of aneurysmal subarachnoid hemorrhage: a systematic review for central nervous system vascular lesions and meta-analysis of ruptured aneurysms. World Neurosurgery 2018; 115: 430-447.e7.
6.
Huiqian F, Weijun W, Yan J, Xiao L, Yang L. Prognostic significance of CXCR7 in cancer patients: a meta-analysis. Cancer Cell Int 2018; 18: 212.
7.
Khey KMW, Huard A, Mahmoud SH. Inflammatory pathways following subarachnoid hemorrhage. Cell Mol Neurobiol 2020; 40: 675-693.
8.
Koenen J, Bachelerie F, Balabanian K, Schlecht-Louf G, Gallego C. Atypical chemokine receptor 3 (ACKR3): a comprehensive overview of its expression and potential roles in the immune system. Mol Pharmacol 2019; 96: 809-818.
9.
Li T, Niu J, Yu G, Ezan P, Yi C, Wang X, Koulakoff A, Gao X, Chen X, Sáez JC, Giaume C, Xiao L. Connexin 43 deletion in astrocytes promotes CNS remyelination by modulating local inflammation. Glia 2020; 68: 1201-1212.
10.
Marchevsky AM, Walts AE, Wick MR. Pathology in the era of “Personalized Medicine”: The need to learn how to integrate multivariate immunohistochemical and “omics” data with clinicopathologic information in a clinically relevant way”. Ann Diagn Pathol 2019; 43: 151410.
11.
Neifert SN, Chapman EK, Martini ML, Shuman WH, Schupper AJ, Oermann EK, Mocco J, Loch Macdonald R. Aneurysmal subarachnoid hemorrhage: the last decade. Transl Stroke Res 2021; 12: 428-446.
12.
Neves M, Fumagalli A, Bor J, Marin P, Smit MJ, Mayor F. The role of ACKR3 in breast, lung and brain cancer. Mol Pharmacol 2019; 96: 819-825.
13.
Osgood ML. Aneurysmal subarachnoid hemorrhage: Review of the pathophysiology and management strategies. Curr Neurol Neurosci Rep 2021; 21: 50.
14.
Patabendige A, Singh A, Jenkins S, Sen J, Chen R. Astrocyte activation in neurovascular damage and repair following ischaemic stroke. Int J Mol Sci 2021; 22: 4280.
15.
P Solár, Brázda V, Levin S, et al. Subarachnoid hemorrhage increases level of heme oxygenase-1 and biliverdin reductase in the choroid plexus. Front Cell Neurosci 2020; 14: 593305-593305.
16.
Ren R, Li Z, Min W. Specific deletion connexin43 in astrocyte ameliorates cognitive dysfunction in APP/PS1 mice. Life Sci 2018; 208: 175-191.
17.
Rouanet C, Silva GS. Aneurysmal subarachnoid hemorrhage: current concepts and updates. Arq Neuropsiquiatr 2019; 77: 806-814.
18.
Rusetska N, Kowalski K, Zalewski K, Zięba S, Bidziński M, Goryca K, Kotowicz B, Fuksiewicz M, Kopczynski J, Bakuła-Zalewska E, Kowalik A, Kowalewska M. CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma. J Clin Pathol 2022; 5: 324-332.
19.
Sharma D. Perioperative management of aneurysmal subarachnoid hemorrhage. Anesthesiology 2020; 133: 1283-1305.
20.
Sung-Ho A, Savarraj JP, Mubashir P, et al. The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes. Neurosurgery 2018; 83: 137-145.
21.
Williams JL, Patel JR, Daniels BP, Klein RS. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system. J Exp Med 2014; 211: 791-799.
22.
Yang L, Yan J, Zhang JA, Zhou XH, Fang C, Zeng EM, Tang B, Duan J, Lu GH, Hong T. The important role of connexin 43 in subarachnoid hemorrhage-induced cerebral vasospasm. J Transl Med 2019; 17: 433.
